Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Alzheimer Disease

Genetics in Medicine - United States
doi 10.1097/gim.0b013e3181d5a68e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Long QT Syndrome

Genetics in Medicine
MedicineGenetics
2010English

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing and Carrier Screening for Tay-Sachs and Canavan Disease

Genetics in Medicine
MedicineGenetics
2010English

Comment on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing: Lessons From Hereditary Hemorrhagic Telangiectasia

Genetics in Medicine
MedicineGenetics
2010English

The Impact of Multiplex Genetic Testing on Disease Risk Perceptions

Clinical Genetics
Genetics
2014English

University Licensing of Patents for Varietal Innovations in Agriculture

Agricultural Economics
AgronomyEconomicsCrop ScienceEconometrics
2016English

Psychosocial Impact of Alzheimer Disease

JAMA - Journal of the American Medical Association
Medicine
1998English

Patenting and Licensing in Genetic Testing: Ethical, Legal and Social Issues

European Journal of Human Genetics
Genetics
2008English

Use of Local Genetic Ancestry to Assess TOMM40-523′ and Risk for Alzheimer Disease

Neurology: Genetics
NeurologyGenetics
2020English

Correction: Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy